| Exome sequencing reveals VCP mutations as a cause of familial ALS JO Johnson, J Mandrioli, M Benatar, Y Abramzon, VM Van Deerlin, ... Neuron 68 (5), 857-864, 2010 | 1432 | 2010 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1268-1283. e6, 2018 | 578 | 2018 |
| Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients G Zuccoli, M Gallucci, J Capellades, L Regnicolo, B Tumiati, TC Giadás, ... American Journal of Neuroradiology 28 (7), 1328-1331, 2007 | 238 | 2007 |
| Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72 A Chiò, G Borghero, G Restagno, G Mora, C Drepper, BJ Traynor, ... Brain 135 (3), 784-793, 2012 | 230 | 2012 |
| Selenium neurotoxicity in humans: bridging laboratory and epidemiologic studies M Vinceti, J Mandrioli, P Borella, B Michalke, A Tsatsakis, Y Finkelstein Toxicology letters 230 (2), 295-303, 2014 | 209 | 2014 |
| Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial JS Mora, A Genge, A Chio, CJ Estol, D Chaverri, M Hernández, S Marín, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (1-2), 5-14, 2020 | 186 | 2020 |
| Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels F Bartolome, HC Wu, VS Burchell, E Preza, S Wray, CJ Mahoney, NC Fox, ... Neuron 78 (1), 57-64, 2013 | 172 | 2013 |
| ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia Q Jiang, LA Crews, CL Barrett, HJ Chun, AC Court, JM Isquith, MA Zipeto, ... Proceedings of the National Academy of Sciences 110 (3), 1041-1046, 2013 | 168 | 2013 |
| Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis S Bandres‐Ciga, AJ Noyce, G Hemani, A Nicolas, A Calvo, G Mora, ... Annals of neurology 85 (4), 470-481, 2019 | 162 | 2019 |
| Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation A Chiò, G Restagno, M Brunetti, I Ossola, A Calvo, G Mora, M Sabatelli, ... Neurobiology of aging 30 (8), 1272-1275, 2009 | 161 | 2009 |
| Genetic counselling in ALS: facts, uncertainties and clinical suggestions A Chiò, S Battistini, A Calvo, C Caponnetto, FL Conforti, M Corbo, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (5), 478-485, 2014 | 152 | 2014 |
| A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis A Chiò, JC Schymick, G Restagno, SW Scholz, F Lombardo, SL Lai, ... Human molecular genetics 18 (8), 1524-1532, 2009 | 147 | 2009 |
| Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite M Vinceti, N Solovyev, J Mandrioli, CM Crespi, F Bonvicini, E Arcolin, ... Neurotoxicology 38, 25-32, 2013 | 128 | 2013 |
| The epidemiology of ALS in Modena, Italy J Mandrioli, P Faglioni, E Merelli, P Sola Neurology 60 (4), 683-689, 2003 | 128 | 2003 |
| FUS mutations in sporadic amyotrophic lateral sclerosis SL Lai, Y Abramzon, JC Schymick, DA Stephan, T Dunckley, A Dillman, ... Neurobiology of aging 32 (3), 550. e1-550. e4, 2011 | 124 | 2011 |
| Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis Y Abramzon, JO Johnson, SW Scholz, JP Taylor, M Brunetti, A Calvo, ... Neurobiology of aging 33 (9), 2231. e1-2231. e6, 2012 | 123 | 2012 |
| Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis? M Vinceti, I Bottecchi, A Fan, Y Finkelstein, J Mandrioli Walter de Gruyter 27 (1), 19-41, 2012 | 114 | 2012 |
| Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial A Chio, G Borghero, A Calvo, M Capasso, C Caponnetto, M Corbo, ... Neurology 75 (7), 619-625, 2010 | 114 | 2010 |
| Factors predicting survival in ALS: a multicenter Italian study A Calvo, C Moglia, C Lunetta, K Marinou, N Ticozzi, GD Ferrante, C Scialo, ... Journal of neurology 264, 54-63, 2017 | 113 | 2017 |
| Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) J Mandrioli, R D’Amico, E Zucchi, A Gessani, N Fini, A Fasano, ... Medicine 97 (24), e11119, 2018 | 112 | 2018 |
